Delivery Order SPE2DR25D1100-SPE2DR26FDF5F
Award Date 2/17/26
Potential Completion Date 3/10/26
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ibrance 125 mg tablets (7s). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2026. The contract provides pharmaceutical and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 18, 2026, with a ceiling value of $34,239.36 for supply of Ibrance 100 mg capsules (21-count packaging). Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 11, 2026. Pricing is firm fixed price. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for IBRANCE 75 MG Tablet 7S with a ceiling value of $8,561.41.</p> <p>The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for Ibrance 125 mg capsules (21-count), with a ceiling value of $8,555.21 under a firm fixed-price arrangement. Place of performance is Conshohocken, PA. Ultimate completion date is February 24, 2026. The order carries no set-aside designation and represents a call against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 3, 2026, with a ceiling value of $17,119.68 for supply of Ibrance 100 mg capsule (21-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 25, 2026. The order is priced firm fixed price and used no set-aside.</p>
- The Defense Logistics Agency awarded a delivery order valued at $8.56K to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (7-count units) under a firm fixed-price contract. The award was issued on January 5, 2026, with a completion date of January 27, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's established capability...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, with a ceiling value of $8,559.84 for Ibrance 100 mg capsule 21-count units.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 3, 2026. Pricing is firm fixed price. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ibrance 125 mg tablets in a quantity of seven units, with a ceiling value of $8,118.08. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $8,122.48 delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (7-count units) with a firm fixed price contract type. The award, issued on October 17, 2025, has an ultimate completion date of November 7, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-count), valued at $8,122.48 under a firm fixed price contract. This non-set-aside delivery order is scheduled for completion by September 3, 2025, with performance of work occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDF5FDelivery Order
The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply to military healthcare programs globally.
Generated 5/19/26, 10:49 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 2/16/26 |